Cart
sales@molnova.com
LSD1-IN-30
CAS No. 1289575-45-6
LSD1-IN-30( —— )
Catalog No. M37358 CAS No. 1289575-45-6
LSD1-IN-30 is a lysine-specific demethylase 1 (LSD1) inhibitor with anticancer activity for the study of small cell lung cancer and acute myeloid leukemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 179 | Get Quote |
|
| 5MG | 282 | Get Quote |
|
| 10MG | 451 | Get Quote |
|
| 25MG | 877 | Get Quote |
|
| 50MG | 1408 | Get Quote |
|
| 100MG | 2205 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLSD1-IN-30
-
NoteResearch use only, not for human use.
-
Brief DescriptionLSD1-IN-30 is a lysine-specific demethylase 1 (LSD1) inhibitor with anticancer activity for the study of small cell lung cancer and acute myeloid leukemia.
-
DescriptionLSD1-IN-30 (compound 3) is a potent inhibitor of lysine-specific demethylase 1 (LSD1), with the IC50 value of 0.291 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorHistone Demethylase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1289575-45-6
-
Formula Weight270.28
-
Molecular FormulaC15H14N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (369.99 mM; Ultrasonic )
-
SMILESC(=N\NC(=O)C1=CC=C(O)C=C1)(\C)/C2=C(O)C=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Venkataswamy Sorna, et al. High-Throughput Virtual Screening Identifies Novel N′?(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors. J Med Chem. 2013 Dec 12;56(23):9496-508.?
molnova catalog
related products
-
SP2509
SP2509 is a potent, selective histone demethylase LSD1 (KDM1A) inhibitor with IC50 of 13 nM.
-
Ethyl 2-amino-4-meth...
Ethyl 2-amino-4-methyl-5-[(3-nitrophenyl)carbamoyl]thiophene-3-carboxylate is a selective inhibitor of histone methyltransferase SETD7 (IC50 = 4.59 μM) with anticancer activity.
-
Dot1L-IN-4
Dot1L-IN-4 is a potent disruptor of telomeric silencing 1-like protein (DOT1L) inhibitor.
